NILKET MEDS PHARMACEUTICAL PRIVATE LIMITED
NILKET MEDS PHARMACEUTICAL PRIVATE LIMITED is a UTTAR PRADESH based PRIVATE LIMITED company, Registered at dated 21-SEP-2024 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of NILKET MEDS PHARMACEUTICAL PRIVATE LIMITED is U46497UP2024PTC209495 and registration number is 209495.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC KANPUR India. Authorized share capital of NILKET MEDS PHARMACEUTICAL PRIVATE LIMITED is Rs. 1500000 and its paid up capital is Rs. 100000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
NILKET MEDS PHARMACEUTICAL PRIVATE LIMITED has 2 directors SHASHANK SRIVASTAV, MADHURI DEVI,
The registered Email address of NILKET MEDS PHARMACEUTICAL PRIVATE LIMITED is heartmeds2024@gmail.com and its registered address is MADAR BHARI RAJNARAIN LAL MADARBHARI AKBERPUR AMBEDKAR NAGAR UP 224132 IN UTTAR PRADESH UTTAR PRADESH india 224132.
The current status of NILKET MEDS PHARMACEUTICAL PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
NILKET MEDS PHARMACEUTICAL PRIVATE LIMITED
ROC KANPUR
ACTIVE
U46497UP2024PTC209495
21-SEP-2024
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1500000
100000
CONTACT DETAILS
224132
INDIA
MADAR BHARI RAJNARAIN LAL MADARBHARI AKBERPUR AMBEDKAR NAGAR UP 224132 IN
heartmeds2024@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
10783426 | SHASHANK SRIVASTAV | Director | 21/09/2024 |
10783427 | MADHURI DEVI | Director | 21/09/2024 |
Details Updated by Companies
Quick Links
- All Registered company of UTTAR PRADESH
- Company Registered in UTTAR PRADESH
- All Registered company of AMBEDKAR NAGAR in UTTAR PRADESH
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.